bioxcel
therapeutics
host
third
quarter
operating
financial
results
conference
call
webcast
new
globe
newswire
bioxcel
therapeutics
bti
company
nasdaq
btai
biopharmaceutical
company
utilizing
artificial
intelligence
identify
improved
therapies
neuroscience
today
announced
host
conference
call
webcast
thursday
november
eastern
time
discuss
third
quarter
operating
financial
results
conference
call
webcast
details
date
time
thursday
november
eastern
time
domestic
international
webcast
accessible
events
news
media
page
company
website
replay
domestic
international
conference
id
replay
available
least
november
bioxcel
therapeutics
bioxcel
therapeutics
clinical
stage
biopharmaceutical
company
focused
drug
development
utilizes
artificial
intelligence
identify
improved
therapies
neuroscience
bti
drug
approach
leverages
existing
approved
drugs
clinically
evaluated
product
candidates
together
big
data
proprietary
machine
learning
algorithms
identify
new
therapeutic
indices
bti
two
advanced
clinical
development
programs
investigational
sublingual
thin
film
formulation
development
acute
treatment
agitation
resulting
neuropsychiatric
disorders
investigational
orally
administered
systemic
innate
immunity
activator
development
treatment
rare
form
prostate
cancer
treatment
pancreatic
cancer
combination
agents
information
please
visit
contact
information
bioxcel
therapeutics
investor
relations
john
graziano
jgraziano
media
julia
deutsch
jdeutsch
